72 reports

  • Risk Factors for Pancreatic Cancer
  • presents the risk factors for pancreatic cancer.

Pancreatic Cancer: Epidemiology Forecast to 2026 Summary Pancreatic cancer is one of the most fatal cancers around the world, with the highest incidence and mortality rates found in developed countries (Michaud, 2004).Pancreatic cancer occurs when cells in the pancreas develop mutations in their...

  • Pancreatic Cancer
  • Japan
  • United States
  • World
  • Forecast
  • Imbruvica's Development in Pancreatic Cancer
  • Napabucasin's Development in Pancreatic Cancer

Pancreatic Cancer: Opportunity Analysis and Forecast to 2026 Summary Pancreatic cancer is set to become the second leading cause of cancer-related deaths in the US in 2020 after lung cancer, despite accounting for only 3% of new cancer diagnoses. Patients with advanced pancreatic cancer have a median...

  • Pancreatic Cancer
  • AbbVie Inc.
  • AstraZeneca PLC
  • Halozyme Therapeutics, Inc.
  • Merck & Co., Inc.

Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pancreatic Cancer
  • France
  • United States
  • World
  • Forecast
  • PANCREATIC CANCER SURVIVAL RATE
  • PROGNOS PANCREATIC CANCER DIAGNOSIS TEST RESULT VARIANCE

Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the...

  • Artificial Intelligence
  • Healthcare
  • Hospital
  • Information Technology
  • Pancreatic Cancer

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • United States
  • Market Size

Pancreatic Cancer -Epidemiology Forecast to 2027 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • Italy
  • Spain

Pancreatic cancer

4546 5000 3864
  • LEADING TREATMENTS FOR PANCREATIC CANCER
  • Forecast: Pancreatic Cancer

The prognosis of patients with pancreatic cancer remains poor; however, this clinical need will drive future market expansion and the development of several targeted therapies. This report addresses the following questions: -What are the current treatment options for patients with pancreatic cancer in each therapeutic...

  • Pancreatic Cancer
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • NewLink Genetics Corporation
  • Taiho Pharmaceutical Co., Ltd.
  • PANCREATIC CANCER THERAPEUTICS, COMMON MUTATIONS IN PANCREATIC CANCER
  • PANCREATIC CANCER THERAPEUTICS, SURVIVAL BY STAGE

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape Summary Pancreatic Cancer (PC) is a disease predominately of the elderly with ~75% of PC cases being diagnosed in patient’s over 75 years old. PC proliferates rapidly, is...

  • Pancreatic Cancer
  • World
  • Forecast
  • Market Size
  • Celgene Corporation

Europe Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pancreatic Cancer
  • Europe
  • France
  • Germany
  • Forecast

Pancreatic Cancer - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Market Shares

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • Italy
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Japan
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • France
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Germany
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Italy
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United Kingdom
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Spain
  • Market Size
  • Staging of Pancreatic Cancer
  • Pancreatic Cancer Tumour Location

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Pancreatic Cancer in 17 Major Markets Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of...

  • Cancer
  • Pancreatic Cancer
  • Pathology

Drug Analysis: Masitinib Product Profiles masitinib : Prostate cancer masitinib : Colorectal cancer (CRC) masitinib : Asthma masitinib : Pancreatic cancer LIST OF FIGURES Figure ##: Masitinib for prostate cancer – SWOT analysis Figure ##: Datamoni

  • Colorectal Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • European Union
  • United States

Drug Overview: Masitinib TABLE OF CONTENTS ## Product Profiles## masitinib : Prostate cancer ## masitinib : Colorectal cancer (CRC) ## masitinib : Asthma ## masitinib : Pancreatic cancer LIST OF FIGURES ## Figure ##: Masitinib for prostate cancer

  • Colorectal Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • European Union
  • United States
  • 4.2 PANCREATIC CANCER - AN OVERVIEW
  • PANCREATIC CANCER - GLOBAL PREVALENCE

Pancreatic Cancer Therapeutics & Diagnostics Market The market is expected to grow modestly from USD 1,730 million in 2015, growing at a CAGR of 10-17%. Globally, pancreatic cancer is the 12th most common cancer in men and 11th most common cancer in women. Addiction to cigarettes and health history are considered...

  • Chemotherapy
  • Pancreatic Cancer
  • United States
  • World
  • Market Size

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U. S.

  • Cancer
  • Pancreatic Cancer
  • United States
  • Forecast
  • Market Size
  • LATEST CLINICAL TRIALS NEWS ON PANCREATIC CANCER
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF PANCREATIC CANCER TO ONCOLOGY CLINICAL TRIALS

Pancreatic Cancer Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Pancreatic Cancer clinical trials scenario.This report provides top line data relating to the clinical trials on...

  • Drug Discovery And Development
  • Pancreatic Cancer
  • Pharmaceutical
  • United States
  • World
  • PANCREATIC CANCER ASSAY - PRODUCT DESCRIPTION
  • NANOMABKV - PANCREATIC CANCER - PRODUCT DESCRIPTION

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Pancreatic Cancer Diagnostic Tests currently in pipeline stage. The report...

  • Cancer
  • Clinical Trial
  • Pancreatic Cancer
  • United States
  • Proteome Sciences

##, ##, ##, ##, ##, ##, ##, ##, ## and ## respectively.

  • Cancer
  • Pancreatic Cancer
  • Pharmaceutical
  • Therapy

Metastatic Pancreatic Cancer Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Metastatic Pancreatic Cancer Trials ## Clinical Trials Trends to ##

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • Pancreatic Cancer
  • Pathology
  • Metastatic Pancreatic Cancer Overview
  • Metastatic Pancreatic Cancer - Dormant Projects

Metastatic Pancreatic Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for...

  • Chemotherapy
  • Pancreatic Cancer
  • United States
  • Company
  • Product Initiative

Pancreatic Cancer Pipeline Highlights – 2017 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Product Initiative
  • Metastatic Pancreatic Cancer Overview
  • Metastatic Pancreatic Cancer - Dormant Projects

Metastatic Pancreatic Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for...

  • Cancer
  • Pancreatic Cancer
  • United States
  • Company
  • Product Initiative